Opendata, web and dolomites

AGEMEC SIGNED

Age-dependent mechanisms of sporadic Alzheimer’s Disease in patient-derived neurons

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AGEMEC project word cloud

Explore the words cloud of the AGEMEC project. It provides you a very rough idea of what is the project "AGEMEC" about.

malfunction    first    links    earliest    impairment    patients    appear    aging    neurons    accounts    preliminary    opens    link    mci    discovered    explore    cancer    understand    overwhelming    exclusively    harness    spec    illuminate    ipsc    manipulating    probably    cellular    manner    signatures    profiling    direct    de    strategies    fibroblasts    assays    age    elusive    ultimate    preserves    sporadic    aerobic    conversion    mass    pathology    profound    epigenetic    ad    disease    people    models    treatment    contrast    mild    metabolite    human    risk    surprisingly    combine    data    connection    permitting    signature    mature    neuropsychiatric    started    glycolysis    majority    patient    regulators    contribution    interesting    anticipate    alzheimer    model    ins    serotonergic    differentiated    fail    mechanisms    agnostic    landscape    transcriptome    treatable    diseases    neuroscience    suggests    neuronal    glutamatergic    cognitive    avenues    metabolic    interface    metabolome    shows    dependent    mechanistic    switch    differentiation   

Project "AGEMEC" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAET INNSBRUCK 

Organization address
address: INNRAIN 52
city: INNSBRUCK
postcode: 6020
website: http://www.uibk.ac.at

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 1˙499˙565 €
 EC max contribution 1˙499˙565 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-STG
 Funding Scheme ERC-STG
 Starting year 2020
 Duration (year-month-day) from 2020-02-01   to  2025-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAET INNSBRUCK AT (INNSBRUCK) coordinator 1˙499˙565.00

Map

 Project objective

Sporadic Alzheimer’s Disease (AD) accounts for the overwhelming majority of all AD cases and exclusively affects people at old age. However, mechanistic links between aging and AD pathology remain elusive. We recently discovered that in contrast to iPSC models, direct conversion of human fibroblasts into induced neurons (iNs) preserves signatures of aging, and we have started to develop a patient-based iN model system for AD. Our preliminary data suggests that AD iNs show a neuronal but de-differentiated transcriptome signature. In this project, we first combine cellular neuroscience assays and epigenetic landscape profiling to understand how neurons in AD fail to maintain their fully mature differentiated state, which might be key in permitting disease development. Next, using metabolome analysis including mass spec metabolite assessment, we explore a profound metabolic switch in AD iNs that shows surprisingly many aspects of aerobic glycolysis observed also in cancer. While this link might represent an interesting connection between two age-dependent and de-differentiation-associated diseases, it also opens new avenues to harness knowledge from the cancer field to better understand sporadic AD. We further focus on identifying and manipulating key metabolic regulators that appear to malfunction in an age-dependent manner, with the ultimate goal to define potential targets and treatment strategies. Finally, we will focus on early AD mechanisms by extending our model to mild cognitive impairment (MCI) patients. An agnostic transcriptome and epigenetic landscape approach of glutamatergic and serotonergic iNs will help to determine the earliest and probably most treatable disease mechanisms of AD, and to better understand the contribution of neuropsychiatric risk factors. We anticipate that this project will help to illuminate the mechanistic interface of cellular aging and the development of AD, and help to define new strategies for AD.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AGEMEC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AGEMEC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

SuperH (2019)

Discovery and Characterization of Hydrogen-Based High-Temperature Superconductors

Read More  

PROGRESS (2019)

The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More